Working with researchers from the Regional Centre of Advanced Technologies and Materials (RCPTM) at Palacký University and a number of other centers, a team of researchers headed by Pavel Šácha of IOCB’s Jan Konvalinka Group has developed a new method for isolating viral RNA independent of commercially available materials. The researchers optimized the method for laboratory automation in clinical practice, making it possible to isolate nearly a hundred samples at once, and they successfully tested it in collaboration with the Public Health Institute in Ostrava.
Currently, production is being transferred to IOCB subsidiary IOCB Tech, which will oversee distribution in the Czech Republic and Slovakia. IOCB is also conducting licensing negotiations with potential producers.
Read more here.